Cargando…
Safety and Efficacy of Oral Transmucosal Fentanyl Citrate Compared to Morphine Sulphate Immediate Release Tablet in Management of Breakthrough Cancer Pain
AIM: To compare the efficacy and safety of oral transmucosal fentanyl citrate (OTFC) and oral morphine in Indian patients with breakthrough episodes of cancer pain. MATERIALS AND METHODS: In this randomized, open label, active controlled, clinical study, total 186 patients who regularly experienced...
Autores principales: | Bhatnagar, Sushma, Devi, Saraswathi, Vinod, NK, Jain, PN, Durgaprasad, G, Maroo, Sanjaykumar H, Patel, Ketan R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154163/ https://www.ncbi.nlm.nih.gov/pubmed/25191003 http://dx.doi.org/10.4103/0973-1075.138386 |
Ejemplares similares
-
Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain
por: Prommer, Eric, et al.
Publicado: (2012) -
Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain
por: Mercadante, S, et al.
Publicado: (2007) -
A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet
por: Freye, Enno
Publicado: (2008) -
Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology
por: Mystakidou, Kyriaki, et al.
Publicado: (2007) -
Efficacy of Oral Transmucosal Fentanyl Citrate for Premedication in Patients for Surgery under General Anesthesia
por: Singh, Raj Bahadur, et al.
Publicado: (2017)